de Korte, M A <br/><br/>
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Sep 2007 
 - 2046-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2007.06.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anthracyclines--therapeutic use<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--adverse effects<br/>Chronic Disease<br/>Female<br/>Heart Diseases--chemically induced<br/>Heart Failure--metabolism<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardium--metabolism<br/>Neoplasms--drug therapy<br/>Pentetic Acid<br/>Receptor, ErbB-2--metabolism<br/>Stress, Physiological--chemically induced<br/>Tomography, Emission-Computed, Single-Photon--methods<br/>Trastuzumab<br/>Up-Regulation